Cardiol Therapeutics
CRDL----
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Cardiol Therapeutics(CRDL) predict that the EBIT is -6.968 M (-18.35%), Miss estimate;the EPS is -0.0718 (-2.77%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
TBA--
0.00B--
----
EBITMiss expectations
-0.01B18.35%
-0.01B3.23%
-0.00B15.12%
EPSMiss expectations
-0.07182.77%
-0.06467.50%
-0.007210.27%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf